United States · Bill · HR
H.R. 1316 (115th)
Prescription Drug Price Transparency Act
Introduced
2 March 2017
Last action
—
Status
Referred to the Subcommittee on Military Personnel.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Prescription Drug Price Transparency Act This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 2 March 2017
Introduced in House (PDF)
Introduced in House · EN · 2 March 2017
Introduced in House
summary · EN · 2 March 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/1316
- Open data entity: https://api.congress.gov/v3/bill/115/hr/1316